Biktarvy and Cipro drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Biktarvy (bictegravir sodium; emtricitabine; tenofovir alafenamide fumarate) and Cipro (ciprofloxacin hydrochloride). Common drug interactions include anhedonia among females and anhedonia among males.

The phase IV clinical study analyzes what interactions people have when they take Biktarvy and Cipro. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.

What is Biktarvy?

Biktarvy has active ingredients of bictegravir sodium; emtricitabine; tenofovir alafenamide fumarate. It is often used in hiv infection. eHealthMe is studying from 19,543 Biktarvy users. Check the latest studies of Biktarvy.

What is Cipro?

Cipro has active ingredients of ciprofloxacin hydrochloride. It is often used in urinary tract infection. eHealthMe is studying from 35,126 Cipro users. Check the latest studies of Cipro.



On Jul, 11, 2026

23 people who take Biktarvy and Cipro together, and have interactions are studied.

Biktarvy and Cipro drug interactions.

What are the common drug interactions of Biktarvy and Cipro, by gender? *:

female:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Emotional distress
  4. Osteoporosis (bones weak and more likely to break)
  5. Pain
  6. Bone density decreased
  7. Depression
  8. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  9. Osteopenia (a condition where bone mineral density is lower than normal)
  10. Pain in extremity

male:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Tibia fracture (fracture of lower leg bone)
  4. Blood creatinine increased
  5. Hypertension (high blood pressure)
  6. Benign prostatic hyperplasia (benign enlargement of the prostate)
  7. Fracture
  8. Gout (uric acid crystals building up in the body)
  9. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  10. Arteriovenous fistula site complication

What are the common drug interactions of Biktarvy and Cipro, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Emotional distress
  4. Pain
  5. Chronic kidney disease
  6. Osteoporosis (bones weak and more likely to break)
  7. Bipolar disorder (mood disorder)
  8. Bone density decreased
  9. Hypertension (high blood pressure)
  10. Multiple injuries

50-59:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Emotional distress
  4. Pain
  5. Bone density decreased
  6. Osteoporosis (bones weak and more likely to break)
  7. Renal impairment (severely reduced kidney function)
  8. Blood creatinine increased
  9. Benign prostatic hyperplasia (benign enlargement of the prostate)
  10. Fracture

60+:

  1. Chronic kidney disease
  2. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  3. Renal impairment (severely reduced kidney function)
  4. Renal failure (kidney dysfunction)
  5. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  6. Anxiety
  7. Arteriovenous fistula site complication
  8. Emotional distress
  9. Gait disturbance
  10. Injury

What are the existing conditions these people have? *

  1. Pain: 3 people, 13.04%
  2. Infection: 2 people, 8.70%
  3. High Blood Pressure: 2 people, 8.70%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 8.70%
  5. Dyspnea (difficult or laboured breathing): 2 people, 8.70%
  6. Bronchitis Bacterial (inflammation of the mucous membrane in the bronchial tubes due to bacterial infection): 2 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Biktarvy and Cipro?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Biktarvy and Cipro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Biktarvy:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cipro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Biktarvy and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cipro and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on bictegravir sodium; emtricitabine; tenofovir alafenamide fumarate and ciprofloxacin hydrochloride (the active ingredients of Biktarvy and Cipro, respectively), and Biktarvy and Cipro (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: